The DEA is likely to change its federal designation for cannabis in the coming months. It's a good sign for research and for the ability of Americans to receive medical treatments involving the plant, but descheduling and ending federal prohibition is still a worthy goal. Jeff Singer explains.
Hosted on Acast. See acast.com/privacy for more information.
